Two new board members were recently announced by Cumberland Emerging Technologies, Inc. (CET), a joint initiative between Cumberland Pharmaceuticals, Vanderbilt University, Launch Tennessee, and Gloria Pharmaceuticals.

Robert Grajewski is the Evans Family Executive Director of the Innovation Center at Vanderbilt University, where he serves as the primary liaison between the center and the Vanderbilt community. Grajewski works with students to encourage innovation and to motivate them to pursue projects that transform the way we live. He has an MBA from The Wharton School at the University of Pennsylvania, an MPA from Harvard Kennedy School and an AB degree from Harvard University.

Samuel M. Lawrence

Samuel M. Lawrence is CEO and a co-founder of the scientific imaging and instrumentation company CytoViva, Inc., where he led the development of their core, patented illumination technology. He is co-inventor on two U.S. Patents for innovative insulation materials for commercial airplanes. Lawrence holds a BS in Aerospace Engineering from Mississippi State University and a Masters of Management in Manufacturing from the Northwestern University Kellogg Graduate School of Management.